US Stock MarketDetailed Quotes

ELTX Elicio Therapeutics

Watchlist
  • 4.260
  • +0.100+2.40%
Close Oct 31 16:00 ET
  • 4.260
  • 0.0000.00%
Post 16:04 ET
45.90MMarket Cap-1130P/E (TTM)

About Elicio Therapeutics Company

Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.

Company Profile

SymbolELTX
Company NameElicio Therapeutics
Listing DateFeb 5, 2021
Founded2011
CEOMr. Robert Connelly
MarketNASDAQ
Employees32
Fiscal Year Ends12-31
Address451 D Street,5th floor, Suite 501
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02210
Phone1-857-209-0050
Websitehttp://www.elicio.com

Company Executives

  • Name
  • Position
  • Salary
  • Robert Connelly
  • Chief Executive Officer, President, Director, Principal Accounting Officer and Principal Financial Officer
  • 678.30K
  • Dr. Peter DeMuth, PhD
  • Chief Scientific Officer
  • --
  • Dr. Christopher Haqq, M.D.,PhD
  • Executive Vice President, Head of Research and Development and Chief Medical Officer
  • 673.82K
  • Dr. Julian Ada PhD
  • Chairman of the Board
  • 96.05K
  • Yekaterina Chudnovsky
  • Director
  • 48.68K
  • Dr. Jay R. Venkatesan, M.D.
  • Director
  • 45.76K
  • Dr. Robert R. Ruffolo, Jr, Ph.D
  • Independent Director
  • 63.26K
  • Karen J. Wilson
  • Independent Director
  • 101.02K
  • Carol Gail Ashe
  • Independent Director
  • 71.59K
  • Dr. Allen R. Nissenson,M.D.
  • Independent Director
  • 91.22K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data